Screener / SEC EDGAR /CIK 0000046250 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Chemicals & Allied Products

Hawkins Inc HWKN

Compare with peers Embed
FY2025 at a glance

Sales up 11.2%, free cash flow up to $86.1M

XBRL, from each 10-K
RevenueStatements
$1.1B from $974.4M in FY2024
FY2016FY2025
Net incomeStatements
$81.5M from $84.3M in FY2024
FY2016FY2025
Free cash flowStatements
$86.1M from $70.0M in FY2024
FY2016FY2025
EPS (diluted)Statements
$3.91 from $4.03 in FY2024
FY2016FY2025
Operating marginStatements
11.2% from 12.2% in FY2024
FY2016FY2025
Total debtStatements
$244.0M from $149.0M in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (46)
EPS (ttm)
4.12
Sales (ttm)
1.1B
Net income (ttm)
85.8M
Sales growth
+11.2%
EPS growth
-3.0%
Sales Q/Q
+11.9%
Free cash flow
92.5M
Gross margin
22.4%
Oper. margin
11.1%
Net margin
7.5%
FCF margin
8.1%
ROA
8.5%
R&D / sales
-
Dividend
0.75
Debt/Eq
0.41
Curr. ratio
2.28
Cash
7.1M
Op. cash flow (ttm)
148.8M
EBITDA
173.8M
EBITDA margin
16.0%
Net debt
221.9M
Quick ratio
1.59
Interest cover
8.89
ROIC
11.4%
Payout ratio
19.2%
FCF after stock pay
77.5M
Debt / FCF (years)
2.66
Goodwill / assets
22.6%
Oper. margin low 5y
9.2%
Tax rate
25.4%
Stock pay / sales
0.8%
Shares out.
20.8M
Shares Y/Y
-0.4%
Book / share
27.11
Cash / share
0.34
Sales / share
54.80
Asset turnover
1.13
Inventory turns
10.72
Days sales out.
47
Sales 3Y CAGR
+5.1%
Sales 5Y CAGR
+12.7%
EPS 3Y CAGR
+11.0%
EPS 5Y CAGR
+15.2%
Employees
1,200
Sales / employee
950K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2026

Each fiscal year from its own 10-K · XBRL

Revenue 1.1B +9.4% a year Net income 81.5M +15.4% a year
FY2016 revenue 483.6M · SalesRevenueNet, 0000046250-19-000017 FY2016 net income 22.6M · NetIncomeLoss, 0000046250-19-000017 483.6M FY2016 FY2017 revenue 504.2M · Revenues, 0000046250-20-000027 FY2017 net income -9.2M · NetIncomeLoss, 0000046250-20-000027 504.2M FY2017 FY2018 revenue 556.3M · Revenues, 0000046250-21-000019 FY2018 net income 24.4M · NetIncomeLoss, 0000046250-21-000019 556.3M FY2018 FY2019 revenue 540.2M · Revenues, 0000046250-22-000016 FY2019 net income 28.4M · NetIncomeLoss, 0000046250-22-000016 540.2M FY2019 FY2021 revenue 596.9M · Revenues, 0000046250-23-000015 FY2021 net income 41.0M · NetIncomeLoss, 0000046250-23-000015 596.9M FY2021 FY2022 revenue 774.5M · Revenues, 0000046250-24-000013 FY2022 net income 51.5M · NetIncomeLoss, 0000046250-24-000013 774.5M FY2022 FY2023 revenue 935.1M · Revenues, 0000046250-25-000025 FY2023 net income 60.0M · NetIncomeLoss, 0000046250-25-000025 935.1M FY2023 FY2024 revenue 919.2M · Revenues, 0000046250-26-000018 FY2024 net income 75.4M · NetIncomeLoss, 0000046250-26-000018 919.2M FY2024 FY2025 revenue 974.4M · Revenues, 0000046250-26-000018 FY2025 net income 84.3M · NetIncomeLoss, 0000046250-26-000018 974.4M FY2025 FY2026 revenue 1.1B · Revenues, 0000046250-26-000018 FY2026 net income 81.5M · NetIncomeLoss, 0000046250-26-000018 1.1B FY2026

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2026 (9 years).

From the same starting line, FY2016 to FY2026

Revenue, net income and free cash flow, each set to 100 in FY2016. What happened, from the 10-Ks. Not a forecast.

FY2016 = 100
200 400 100 Revenue: $483.6M in FY2016, $1.1B in FY2026 REVENUE $1.1B · 2.2x Free cash flow: $23.2M in FY2016, $86.1M in FY2026 FREE CASH FLOW $86.1M · 3.7x FY2016 = 100FY2022FY2026
Revenue 2.2x $483.6M to $1.1B
Free cash flow 3.7x $23.2M to $86.1M

Growth per share, FY2015 to FY2026

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +16.4% a year FY2015 $0.86 to FY2026 $3.91, 10 years
Book value per share +10.4% a year FY2015 $9.50 to FY2026 $25.60, 10 years
Free cash flow per share +21.8% a year FY2015 $0.57 to FY2026 $4.13, 10 years
500 1000 100 Book value / share: $9.50 in FY2015, $25.60 in FY2026 BOOK VALUE / SHARE $25.60 · 2.7x FCF / share: $0.57 in FY2015, $4.13 in FY2026 FCF / SHARE $4.13 · 7.2x FY2015 = 100FY2021FY2026

Each line is set to 100 in FY2015, so a line at 200 has doubled. What was filed, not a forecast. A line is left out when it is not above zero in every year.

Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Mar 29, 2026 $3.91$25.60$4.13
Mar 30, 2025 $4.03$21.99$3.34
Mar 31, 2024 $3.59$19.32$5.68
Apr 2, 2023 $2.86$16.66$1.38
Apr 3, 2022 $2.44$14.32$0.68
Mar 28, 2021 $1.93$12.48$1.08
Mar 29, 2020 $1.33$10.96$1.61
Mar 31, 2019 $1.14$10.16$1.65
Apr 1, 2018 -$0.43$9.50$0.36
Apr 2, 2017 $1.06$10.28$1.10
Apr 3, 2016 $0.86$9.50$0.57

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2026 · 10-K XBRL, no share price used

Net current asset value, FY2026, in dollars
  • + Current assets $231.5M
  • − All liabilities $452.3M
  • = Net current asset value -$220.8M
Per share, year by year
Tangible book value, FY2026, in dollars
  • + Shareholders' equity $534.0M
  • − Goodwill $223.0M
  • − Other intangible assets $232.9M
  • = Tangible book value $78.1M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

HWKN against Industrials peers

Among the 258 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+0.7%+11.4%
+11.2%64th of 251 · median +5.7%
Net margin
3.8%13.8%
7.5%138th of 252 · median 8.2%
Return on equity
9.4%27.1%
15.2%121st of 243 · median 15.1%
Free cash flow margin
4.9%15.3%
8.1%140th of 235 · median 9.6%
Debt / equity (less is better)
1.170.38
0.4163rd of 224 · median 0.64
HWKN and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
HWKN Hawkins Inc$1.1B +11.2%22.4%7.5%15.2%8.1%0.41
KAI Kadant Inc$1.2B -0.1%44.4%9.8%11.1%14.6%0.43
AGX Argan Inc$1.2B +8.1%20.9%15.1%35.4%45.9%-
HAYW Hayward Holdings, Inc.$1.2B +6.7%48.0%14.4%10.7%13.6%0.60
PAYO Payoneer Global Inc.$1.1B +7.7%-4.7%7.7%18.6%-
VRRM VERRA MOBILITY Corp$1.0B +11.4%-3.8%14.3%13.7%3.90
All 258 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by segment

From $774.5M of sales to $51.5M of profit FY2022

Revenue to Gross profit: $146.5MRevenue to Cost of revenue: $628.0MGross profit to Operating profit: $71.2MGross profit to Operating expenses: $75.3MOperating profit to Net profit: $51.5MOperating profit to Tax & other: $19.7M Revenue: $774.5M REVENUE $774.5M +30% Y/Y Gross profit: $146.5M · 19% margin GROSS PROFIT $146.5M 19% margin · +18% Y/Y Cost of revenue: $628.0M · 81% of revenue COST OF REVENUE $628.0M 81% of revenue Operating profit: $71.2M · 9% margin OPERATING PROFIT $71.2M 9% margin · +27% Y/Y Operating expenses: $75.3M · 10% of revenue OPERATING EXPENSES $75.3M 10% of revenue Net profit: $51.5M · 7% margin NET PROFIT $51.5M 7% margin · +26% Y/Y Tax & other: $19.7M · 3% of revenue TAX & OTHER $19.7M 3% of revenue

From $935.1M of sales to $60.0M of profit FY2023

  • Water Treatment $304.9M
  • Industrial $470.8M
  • Health and Nutrition $159.4M
Revenue to Gross profit: $165.1MRevenue to Cost of revenue: $770.0MGross profit to Operating profit: $88.2MGross profit to Operating expenses: $77.0MOperating profit to Net profit: $60.0MOperating profit to Tax & other: $28.1M Revenue: $935.1M REVENUE $935.1M +21% Y/Y Gross profit: $165.1M · 18% margin GROSS PROFIT $165.1M 18% margin · +13% Y/Y Cost of revenue: $770.0M · 82% of revenue COST OF REVENUE $770.0M 82% of revenue Operating profit: $88.2M · 9% margin OPERATING PROFIT $88.2M 9% margin · +24% Y/Y Operating expenses: $77.0M · 8% of revenue OPERATING EXPENSES $77.0M 8% of revenue Net profit: $60.0M · 6% margin NET PROFIT $60.0M 6% margin · +16% Y/Y Tax & other: $28.1M · 3% of revenue TAX & OTHER $28.1M 3% of revenue

From $919.2M of sales to $75.4M of profit FY2024

Revenue to Gross profit: $193.6MRevenue to Cost of revenue: $725.5MGross profit to Operating profit: $104.0MGross profit to Operating expenses: $89.6MOperating profit to Net profit: $75.4MOperating profit to Tax & other: $28.7M Revenue: $919.2M REVENUE $919.2M −2% Y/Y Gross profit: $193.6M · 21% margin GROSS PROFIT $193.6M 21% margin · +17% Y/Y Cost of revenue: $725.5M · 79% of revenue COST OF REVENUE $725.5M 79% of revenue Operating profit: $104.0M · 11% margin OPERATING PROFIT $104.0M 11% margin · +18% Y/Y Operating expenses: $89.6M · 10% of revenue OPERATING EXPENSES $89.6M 10% of revenue Net profit: $75.4M · 8% margin NET PROFIT $75.4M 8% margin · +26% Y/Y Tax & other: $28.7M · 3% of revenue TAX & OTHER $28.7M 3% of revenue

From $974.4M of sales to $84.3M of profit FY2025

Revenue to Gross profit: $225.5MRevenue to Cost of revenue: $748.9MGross profit to Operating profit: $119.2MGross profit to Operating expenses: $106.4MOperating profit to Net profit: $84.3MOperating profit to Tax & other: $34.8M Revenue: $974.4M REVENUE $974.4M +6% Y/Y Gross profit: $225.5M · 23% margin GROSS PROFIT $225.5M 23% margin · +16% Y/Y Cost of revenue: $748.9M · 77% of revenue COST OF REVENUE $748.9M 77% of revenue Operating profit: $119.2M · 12% margin OPERATING PROFIT $119.2M 12% margin · +15% Y/Y Operating expenses: $106.4M · 11% of revenue OPERATING EXPENSES $106.4M 11% of revenue Net profit: $84.3M · 9% margin NET PROFIT $84.3M 9% margin · +12% Y/Y Tax & other: $34.8M · 4% of revenue TAX & OTHER $34.8M 4% of revenue

From $1.1B of sales to $81.5M of profit FY2026

  • Water Treatment $543.3M
  • Food and Health Sciences $320.7M
  • Industrial Solutions $219.7M
Revenue to Gross profit: $245.1MRevenue to Cost of revenue: $838.6MGross profit to Operating profit: $121.3MGross profit to Operating expenses: $123.8MOperating profit to Net profit: $81.5MOperating profit to Tax & other: $39.7M Revenue: $1.1B REVENUE $1.1B +11% Y/Y Gross profit: $245.1M · 23% margin GROSS PROFIT $245.1M 23% margin · +9% Y/Y Cost of revenue: $838.6M · 77% of revenue COST OF REVENUE $838.6M 77% of revenue Operating profit: $121.3M · 11% margin OPERATING PROFIT $121.3M 11% margin · +2% Y/Y Operating expenses: $123.8M · 11% of revenue OPERATING EXPENSES $123.8M 11% of revenue Net profit: $81.5M · 8% margin NET PROFIT $81.5M 8% margin · −3% Y/Y Tax & other: $39.7M · 4% of revenue TAX & OTHER $39.7M 4% of revenue

Where each $100 of sales went

FY2022
FY2023
FY2024
FY2025
FY2026
  • Cost of revenue
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2026 against FY2021 · 10-K XBRL, year-end balances

Return on equity 15.3% FY2021: 15.4% net income ÷ equity
Net margin 7.5% FY2021: 6.9% profit per $ of sales: 81.5M ÷ 1.1B
Asset turnover 1.10× FY2021: 1.26× sales per $ of assets: 1.1B ÷ 986.3M
Leverage 1.85× FY2021: 1.78× assets per $ of equity: 986.3M ÷ 534.0M

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    7.5% vs 8.2%
  • Gross margin up over 5 years
    20.7% → 22.6%
  • Return on equity above 15%
    15.2%
  • A profit in 9 of 10 years
Net margin, FY2016 to FY2026: 4.7% to 7.5%

Balance sheet

  • Interest covered more than 5 times
    Operating income is 8.9× interest expense
  • Debt smaller than equity
    Debt / equity 0.41 on the latest balance sheet (peer median 0.64)
  • Current assets cover current liabilities
    Current ratio 2.28
  • Net debt under 3 years of free cash flow
    $221.9M net debt, 2.4 years
Debt / equity at each year end, FY2016 to FY2026: 0.47 to 0.46

Cash and shareholders

  • Free cash flow positive in every one of 10 years
    $86.1M last year
  • Share count down over 5 years
    −1.9%
  • Dividend per share up over 5 years
    $0.47 → $0.75
  • Cash from operations above net income
    $144.3M vs $81.5M
Free cash flow, FY2016 to FY2026: 23.2M to 86.1M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities, current part

Paid in advance $612K cash received before delivery, not yet recognized as revenue, Sep 27, 2026

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

HWKN's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue1.1B
FY2016: 483.6MFY2017: 504.2MFY2018: 556.3MFY2019: 540.2MFY2020: 596.9MFY2021: 774.5MFY2022: 935.1MFY2023: 919.2MFY2024: 974.4MFY2025: 1.1B FY2017FY2019FY2021FY2023FY2025
Net income81.5M
FY2016: 22.6MFY2017: -9.2MFY2018: 24.4MFY2019: 28.4MFY2020: 41.0MFY2021: 51.5MFY2022: 60.0MFY2023: 75.4MFY2024: 84.3MFY2025: 81.5M FY2017FY2019FY2021FY2023FY2025
Free cash flow86.1M
FY2016: 23.2MFY2017: 7.6MFY2018: 35.4MFY2019: 34.4MFY2020: 23.0MFY2021: 14.3MFY2022: 29.1MFY2023: 119.3MFY2024: 70.0MFY2025: 86.1M FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay77.5M
FY2016: 21.1MFY2017: 6.3MFY2018: 33.4MFY2019: 32.1MFY2020: 19.7MFY2021: 10.5MFY2022: 25.3MFY2023: 114.5MFY2024: 63.5MFY2025: 77.5M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)3.91
FY2016: 1.06FY2017: -0.43FY2018: 1.14FY2019: 1.33FY2020: 1.93FY2021: 2.44FY2022: 2.86FY2023: 3.59FY2024: 4.03FY2025: 3.91 FY2017FY2019FY2021FY2023FY2025
Dividend per share0.75
FY2016: 0.42FY2017: 0.44FY2018: 0.34FY2019: 0.46FY2020: 0.47FY2021: 0.52FY2022: 0.57FY2023: 0.63FY2024: 0.70FY2025: 0.75 FY2017FY2019FY2021FY2023FY2025
Diluted shares20.9M
FY2016: 21.2MFY2017: 21.3MFY2018: 21.5MFY2019: 21.3MFY2020: 21.3MFY2021: 21.1MFY2022: 21.0MFY2023: 21.0MFY2024: 20.9MFY2025: 20.9M FY2017FY2019FY2021FY2023FY2025

The segments changed

10-K filed May 13, 2026

Compared with the 10-K of May 14, 2025: new segments Food and Health Sciences, Industrial Solutions; no longer reported: Health and Nutrition, Industrial.

Effective beginning with the first quarter of fiscal 2026, we realigned our reporting segments to better reflect how we manage our operations and allocate resources. 10-K

When a company changes its segments, the years before are usually recast, so growth by segment is not comparable with what earlier 10-Ks showed. Found by comparing the segments with revenue in the last two 10-Ks (XBRL) and by the 10-K's own words, without AI.

Revenue by business segment

year to Mar 29, 2026
RevenueSharevs year before
Water Treatment 543.3M50.1% +21.7%
Food and Health Sciences 320.7M29.6% -0.6%
Industrial Solutions 219.7M20.3% +7.0%

10-K 0000046250-26-000018, segment and revenue notes (XBRL).

Revenue by product or service

year to Mar 29, 2026
RevenueSharevs year before
Manufactured, blended or repackaged products 656.3M60.6% +18.7%
Nutrition 138.0M12.7% -4.5%
Food 99.3M9.2% -4.0%
Bulk products 96.2M8.9% +9.4%
Agricultural 52.6M4.9% +15.0%
Pharmaceutical 27.9M2.6% +7.8%
Other 13.5M1.2% -4.9%

10-K 0000046250-26-000018, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Water Treatment228.1M304.9M363.3M446.5M543.3M
Food and Health Sciences--334.6M322.6M320.7M
Industrial Solutions--221.3M205.4M219.7M
Health and Nutrition159.5M159.4M146.4M145.5M-
Industrial386.9M470.8M409.5M382.5M-

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Water Treatment23.2M31.5M52.9M59.5M68.1M
Food and Health Sciences--38.7M41.2M34.4M
Industrial Solutions--12.5M18.4M18.9M
Health and Nutrition16.5M14.3M11.6M14.5M-
Industrial31.5M42.4M39.2M45.1M-

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Segments changed: FY2021, FY2022, FY2023, FY2024 are in italics, as first reported under the earlier segments, so they are not comparable with the later years. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue483.6M504.2M556.3M540.2M596.9M774.5M935.1M919.2M974.4M1.1B
Cost of revenue385.5M417.4M460.4M439.3M473.1M628.0M770.0M725.5M748.9M838.6M
Gross profit98.1M86.8M95.9M100.9M123.8M146.5M165.1M193.6M225.5M245.1M
SG&A59.4M59.4M59.1M59.2M67.9M75.3M77.0M89.6M106.4M123.8M
Operating income38.7M-11.8M36.8M41.7M55.9M71.2M88.2M104.0M119.2M121.3M
Interest expense-3.0M3.2M2.4M1.3M1.2M4.8M4.7M5.8M13.7M
Pretax income36.0M-15.1M33.5M39.0M55.9M70.0M82.6M101.1M114.4M109.3M
Income tax13.5M-5.9M9.1M10.6M14.9M18.4M22.5M25.8M30.0M27.8M
Net income22.6M-9.2M24.4M28.4M41.0M51.5M60.0M75.4M84.3M81.5M
EPS (diluted)1.06-0.431.141.331.932.442.863.594.033.91
Diluted shares21.2M21.3M21.5M21.3M21.3M21.1M21.0M21.0M20.9M20.9M
Depreciation & amortization20.9M22.4M21.8M21.6M22.7M24.1M27.4M31.8M39.9M52.5M
EBITDA59.6M10.6M58.6M63.3M78.5M95.3M115.6M135.8M159.1M173.8M
Gross margin20.3%17.2%17.2%18.7%20.7%18.9%17.7%21.1%23.1%22.6%
Operating margin8.0%-2.3%6.6%7.7%9.4%9.2%9.4%11.3%12.2%11.2%
Net margin4.7%-1.8%4.4%5.3%6.9%6.7%6.4%8.2%8.7%7.5%
Revenue growth+16.8%+4.3%+10.3%-2.9%+10.5%+29.8%+20.7%-1.7%+6.0%+11.2%
EPS growth+23.8%to a loss-+16.7%+45.1%+26.4%+17.2%+25.5%+12.3%-3.0%

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow44.9M27.3M48.0M58.9M43.8M42.8M77.4M159.5M111.1M144.3M
Capital spending21.6M19.7M12.6M24.5M20.8M28.5M48.3M40.2M41.1M58.2M
Free cash flow23.2M7.6M35.4M34.4M23.0M14.3M29.1M119.3M70.0M86.1M
Stock-based pay (added back)2.1M1.4M2.0M2.3M3.3M3.8M3.8M4.9M6.5M8.6M
Free cash flow after stock pay21.1M6.3M33.4M32.1M19.7M10.5M25.3M114.5M63.5M77.5M
Dividends paid8.7M9.2M12.0M9.8M10.0M11.1M12.0M13.2M14.6M15.7M
Acquisitions2.2M00051.0M21.5M083.5M87.4M167.1M
Debt repaid5.6M8.1M85.0M00-----
Investing cash flow-23.5M-19.3M-12.3M-24.2M-71.4M-49.8M-41.2M-122.5M-128.0M-224.1M
Financing cash flow-34.5M-9.9M-31.4M-39.6M26.4M7.4M-32.1M-37.4M14.8M78.6M
Dividend per share0.420.440.340.460.470.520.570.630.700.75

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)2.1M1.4M2.0M2.3M3.3M3.8M3.8M4.9M6.5M8.6M
Stock-based pay / revenue0.4%0.3%0.4%0.4%0.6%0.5%0.4%0.5%0.7%0.8%
Operating lease cash paid-002.0M1.8M1.9M2.0M2.7M3.5M3.8M
Right-of-use assets--09.1M11.6M10.6M10.2M11.7M13.4M16.8M
Operating lease liabilities--10.4M9.2M11.8M10.8M10.4M12.0M13.8M17.5M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HWKN/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.